Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Momentus (MNTS) Change in Accured Expenses (2020 - 2025)

Momentus (MNTS) has disclosed Change in Accured Expenses for 6 consecutive years, with -$1.3 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 24980.0% to -$1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$734000.0 through Dec 2025, down 14580.0% year-over-year, with the annual reading at -$734000.0 for FY2025, 14580.0% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$1.3 million at Momentus, down from $250000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $2.5 million in Q3 2021, with the low at -$4.5 million in Q4 2021.
  • Average Change in Accured Expenses over 5 years is -$205315.8, with a median of $80000.0 recorded in 2021.
  • The sharpest move saw Change in Accured Expenses skyrocketed 10048.37% in 2021, then crashed 24980.0% in 2025.
  • Over 5 years, Change in Accured Expenses stood at -$4.5 million in 2021, then skyrocketed by 144.08% to $2.0 million in 2022, then tumbled by 270.21% to -$3.4 million in 2023, then surged by 99.85% to -$5000.0 in 2024, then plummeted by 24980.0% to -$1.3 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$1.3 million, $250000.0, and $143000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.